Federal Bankruptcy Court Approves DOJ's $8 Billion Global Settlement with Purdue Pharma

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Federal Bankruptcy Court Approves DOJ's $8 Billion Global Settlement with Purdue Pharma

Dennis Tosh

November 18, 2020 at 16:56:04 ET

A federal bankruptcy court in New York Nov. 17 approved an $8 billion global settlement between the opioid manufacturer Purdue Pharma L.P. and the Department of Justice (DOJ) over the objections of some members of Congress and 25 state attorneys general (In re Purdue Pharma L.P., No. 7:19-bk-23649-RDD (Bankr. S.D.N.Y.)). The action by the U.S. Bankruptcy Court for the Southern Dist... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Federal Bankruptcy Court Approves DOJ's $8 Billion Global Settlement with Purdue Pharma

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT